(Q34303415)

1 August 2017

1 reference

title

Newer HMG-CoA reductase inhibitor (statin) therapies (English)

1 reference

1 August 2017

E A Brinton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655011&resulttype=core&format=json

15 May 2020

publication date

1 January 2001

1 reference

1 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655011&resulttype=core&format=json

15 May 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655011&resulttype=core&format=json

15 May 2020

issue

7 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655011&resulttype=core&format=json

15 May 2020

page(s)

II-10-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655011&resulttype=core&format=json

Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia

15 May 2020

cites work

1 reference

12 December 2020

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

12 December 2020

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

1 reference

12 December 2020

Impact of evidence-based "clinical judgment" on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data. National Health and Nutrition Examination Survey.

1 reference

12 December 2020

Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide

1 reference

12 December 2020

Pleiotropic effects of statins in atherosclerosis and diabetes

1 reference

12 December 2020

An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro

1 reference

12 December 2020

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

12 December 2020

Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis

1 reference

12 December 2020

Identifiers

DOI

10.1002/CLC.4960240705

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655011&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655011&resulttype=core&format=json

15 May 2020

11444648

1 reference